PTK2 and cancer: The interaction of NEDD9 with FAK and Src leads to the tyrosine phosphorylation of NEDD9 to generate binding sites for effector proteins, including the Rac and the Cas-Crk complex, which then regulate and activate transcription pathways involved in metastasis and cancer progression (15).